2018 Annual Meeting | C193 - Assessment of Rapidly Progressive Dementias I: Overview, Infections Presenting as Rapidly Progressive Dementia and Antibody-Mediated Rapidly Progressive Dementia
| 01:00 PM - 01:05 PM | Luncheon |
Introduction
Michael D. Geschwind, MD, PhD, FAAN |
| 01:05 PM - 01:55 PM | Speaker |
Infectious Causes of Rapidly Progressive Dementias
Allen J. Aksamit, Jr., MD, FAAN |
| 01:55 PM - 02:45 PM | Speaker |
Assessment of Rapidly Progressive Dementias: Antibody-mediated Encephalopathies
Steven Vernino, MD, PhD, FAAN |
| 02:45 PM - 03:00 PM | Q&A |
Questions and Answers
|
| Michael D. Geschwind, MD, PhD, FAAN | Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainstorm Cell Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Walter Grubb. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reata Pharmaceuticals, Inc.. |
| Steven Vernino, MD, PhD, FAAN | Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for antag. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Autonomic Neuroscience (Elsevier). The institution of Dr. Vernino has received research support from Takeda. The institution of Dr. Vernino has received research support from NIH/NHLBI. The institution of Dr. Vernino has received research support from Dysautonomia International. Dr. Vernino has received personal compensation in the range of $10,000-$49,999 for serving as a Content Expert Consultant with Office of Inspector General for Medicare. Dr. Vernino has a non-compensated relationship as a Board of Directors with American Autonomic Society that is relevant to AAN interests or activities. |
| Allen J. Aksamit, Jr., MD, FAAN | Dr. Aksamit has nothing to disclose. |